This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS

Five‐year outcomes following a randomized trial of femorofemoral and femoropopliteal bypass grafting with heparin‐bonded or standard polytetrafluoroethylene grafts. BJS 2016; 103: 1300-1305.

Published: 1st August 2016

Authors: J. S. Lindholt, K. Houlind, B. Gottschalksen, C. N. Pedersen, H. Ravn, B. Viddal et al.

Background

Cohort studies suggest superior long‐term patency of luminal heparin‐bonded polytetrafluoroethylene (Hb‐PTFE) bypass grafts compared with standard PTFE grafts. The aim of this study was to compare the outcomes of Hb‐PTFE grafts with those of standard PTFE grafts 5 years after a randomized trial.

Method

Patients with intermittent claudication or critical limb ischaemia requiring femorofemoral or femoropopliteal bypass grafting were randomized in a clinical trial of Hb‐PTFE versus standard PTFE in 11 Scandinavian centres between 2005 and 2009. Patients were followed up for 5 years with clinical assessment and surveillance Duplex ultrasound imaging. The primary endpoint of this study was primary patency. Secondary endpoints included major amputation and mortality.

Results

Overall, 569 patients were enrolled in the randomized trial. Some 552 had follow‐up data available for analysis of the primary outcome. Use of Hb‐PTFE significantly improved patency by 37 per cent at 2 years, but 5 years after randomization there was no difference in primary patency (adjusted hazard ratio (HR) 0·95, 95 per cent c.i. 0·71 to 1·28; P = 0·748). In patients with critical limb ischaemia the use of Hb‐PTFE reduced the 5‐year risk of loss of primary patency by 37 per cent (HR 0·63, 0·40 to 0·99; P = 0·049).

Conclusion

In this study there was no difference in primary graft patency between Hb‐PTFE and standard PTFE grafts. Patients receiving Hb‐PTFE grafts for critical limb ischaemia were more likely to have a patent graft at 5 years than those with standard PTFE grafts.

Full text

You may also be interested in

Original article

Sex differences in repair rates and outcomes of patients with ruptured abdominal aortic aneurysm. BJS 2019; 106: 1480-1487.

Authors: S. Zommorodi, M. Bottai, R. Hultgren

Original article

Observational study of the medical management of patients with peripheral artery disease.

Authors: A. Saratzis, N. E. M. Jaspers, B. Gwilym, O. Thomas, A. Tsui, R. Lefroy et al.

Original article

Predicting reamputation risk in patients undergoing lower extremity amputation due to the complications of peripheral artery disease and/or diabetes. BJS 2019; 106: 1026-1034.

Authors: J. M. Czerniecki, M. L. Thompson, A. J. Littman, E. J. Boyko, G. J. Landry, W. G. Henderson et al.

Original article

Health gains, costs and cost‐effectiveness of a population‐based screening programme for abdominal aortic aneurysms. BJS 2019; 106: 1043-1054.

Authors: N. Nair, G. Kvizhinadze, G. T. Jones, R. Rush, M. Khashram, J. Roake et al.

Original article

Development and validation of a gene expression test to identify hard‐to‐heal chronic venous leg ulcers. BJS 2019; 106: 1035-1042.

Authors: D. C. Bosanquet, A. J. Sanders, F. Ruge, J. Lane, C. A. Morris, W. G. Jiang et al.

Randomized clinical trial

Randomized clinical trial of endovenous laser ablation versus direct and indirect radiofrequency ablation for the treatment of great saphenous varicose veins. BJS 2019; 106: 998-1004.

Authors: S. A. S. Hamann, L. Timmer‐de Mik, W. M. Fritschy, G. R. R. Kuiters, T. E. C. Nijsten, R. R. Bos et al.

Systematic review

Meta‐analysis of the outcomes of treatment of internal carotid artery near occlusion. BJS 2019; 106: 665-671.

Authors: A. J. A. Meershoek, E. E. Vries, D. Veen, H. M. Ruijter, G. J. Borst, A. Garcia‐Pastor et al.

Original article

Contemporary prevalence of carotid stenosis in patients presenting with ischaemic stroke. BJS 2019; 106: 872-878.

Authors: S. F. Cheng, M. M. Brown, R. J. Simister, T. Richards

Original article

Baseline findings of the population‐based, randomized, multifaceted Danish cardiovascular screening trial (DANCAVAS) of men aged 65–74 years. BJS 2019; 106: 862-871.

Authors: J. S. Lindholt, L. M. Rasmussen, R. Søgaard, J. Lambrechtsen, F. H. Steffensen, L. Frost et al.

Randomized clinical trial

Randomized clinical trial of mechanochemical and endovenous thermal ablation of great saphenous varicose veins. BJS 2019; 106: 548-554.

Authors: S. Vähäaho, O. Mahmoud, K. Halmesmäki, A. Albäck, K. Noronen, P. Vikatmaa et al.

Systematic review

Meta‐analysis of long‐term survival after elective endovascular or open repair of abdominal aortic aneurysm. BJS 2019; 106: 523-533.

Authors: R. M. A. Bulder, E. Bastiaannet, J. F. Hamming, J. H. N. Lindeman

Original article

Mortality prediction following non‐traumatic amputation of the lower extremity. BJS 2019; 106: 879-888.

Authors: D. C. Norvell, M. L. Thompson, E. J. Boyko, G. Landry, A. J. Littman, W. G. Henderson et al.